Trending...
- California prioritized fighting organized retail theft, those results are paying off with 36,000 arrests and $293 million in stolen goods recovered - 115
- California and the Australian state of Queensland ink new partnership to accelerate climate resilience, agricultural technology, and innovation - 111
- California's public safety strategy works: Governor Newsom's commitment helps lower crime as new study shows violence prevention saves lives
A plate-based fluorometric assay designed to screen, study and characterize potential inhibitors of CD38 cyclase activity.
MILPITAS, Calif. - Californer -- Cluster of differentiation 38 (CD38), also known as cyclic ADP ribose hydrolase or ADP-ribosyl cyclase is a multifunctional enzyme that catalyzes the synthesis and hydrolysis of Nicotinamide Adenine Dinucleotide (NAD) to Nicotinamide and ADP-ribose (ADPR). Additionally, CD38 generates second messengers, cyclic ADP-ribose using NAD as the substrate. Due to its role in NAD+ metabolism, the study of CD38 and its functions has been of great importance.
It is found on the surface of many immune cells, including plasma B cells, natural killer cells, CD4+, CD8+, etc. Elevated levels of CD38 are associated with aging, obesity, diabetes, heart disease, asthma, inflammation and tumorigenesis etc. BioVision's CD38 (Cyclase) Inhibitor Screening Kit is a plate-based fluorometric assay designed to screen, study and characterize potential inhibitors of CD38 cyclase activity. The assay utilizes a selective CD38 substrate to generate a fluorescent signal measured at Ex/Em = 300/410 nm.
More on The Californer
In the presence of potential CD38 cyclase inhibitors, the fluorescent signal is reduced. The assay is quick, easy, and sensitive for high-throughput screening of CD38 inhibitors. Additionally, the kit includes a CD38 Inhibitor as a control inhibitor.
Figure: Inhibition of CD38 cyclase activity by Quercetin. IC50 was calculated to be 5.2 ± 0.8 μM. Assay was performed following the kit protocol.
Storage Conditions -20ºC
USAGE For Research Use Only! Not For Use in Humans.
For more information on this Assay Kit Cat# K2102 https://bit.ly/30wP71F
It is found on the surface of many immune cells, including plasma B cells, natural killer cells, CD4+, CD8+, etc. Elevated levels of CD38 are associated with aging, obesity, diabetes, heart disease, asthma, inflammation and tumorigenesis etc. BioVision's CD38 (Cyclase) Inhibitor Screening Kit is a plate-based fluorometric assay designed to screen, study and characterize potential inhibitors of CD38 cyclase activity. The assay utilizes a selective CD38 substrate to generate a fluorescent signal measured at Ex/Em = 300/410 nm.
More on The Californer
- Apple Valley Home Sales Rise 22.0% as Active Listings Fall 20.2%
- Banafsheh Sayyad Offers a Free Sacred Dance Experience to Awaken Focus and Presence
- Long Beach Public Health Laboratory Now Offering Accredited Environmental Lead Testing Services
- French Camp Academy Releases New Video Inviting Individuals to Consider a Life of Service
- Calder Capital's Growth Continues with Expansion into Southern California
In the presence of potential CD38 cyclase inhibitors, the fluorescent signal is reduced. The assay is quick, easy, and sensitive for high-throughput screening of CD38 inhibitors. Additionally, the kit includes a CD38 Inhibitor as a control inhibitor.
Figure: Inhibition of CD38 cyclase activity by Quercetin. IC50 was calculated to be 5.2 ± 0.8 μM. Assay was performed following the kit protocol.
Storage Conditions -20ºC
USAGE For Research Use Only! Not For Use in Humans.
For more information on this Assay Kit Cat# K2102 https://bit.ly/30wP71F
Source: BioVision Inc
0 Comments
Latest on The Californer
- Qscription Technologies and NEOPATHOLOGY CORP. Sign MOU to Bring FDA-Cleared Lung Imaging AI into U.S. Clinical Practice
- NITE-E-NIGHT: The Future of Gaming Is Live
- Long Beach to Launch Time Capsule Honoring America's 250th Anniversary as Part of 908 Day Celebration
- Long Beach Airport Celebrates Alaska Airlines' Twice-Daily Nonstop Flight Service to Seattle
- Vallejo Home Prices Are Down—So Why Are So Many Homes Still Selling Over Asking?
- Newport Harbor and Corona del Mar Set for Battle of the Bay Showdown at Davidson Field
- City of Long Beach Issues Heat Alert and Advises Residents to Take Precautions Against Heat
- Five International Travel Deals for Seniors Start at Just $995
- Interpreters Unlimited Recognized Among San Diego's 2026 Companies That Care
- IEI Launches Itten-E315, a 31.5-Inch Six-Color ePaper Display
- Impact & Influence April 2026: Joel Rodriguez Tirado on Renewal,Growth & Uncomfortable Conversations
- Franchise Operators Are Standardizing Compliance Across Every Location in 2026
- Impact & Influence March 2026: Joel Rodriguez Tirado - Why You're Still Waiting & The Power of Start
- New Comparison Helps Senior Travelers Weigh Overseas Adventure Travel Against Road Scholar
- Heritage at Manalapan Welcomes New Sales Team as Luxury Single-Family Home Community Continues to Grow
- Applications Now Open for the 2027 BrightEdge Entrepreneurs Program
- Mandeville Pests May Pose Serious Health Risks for Your Family
- xBxBio Advances Connected Cardiovascular Intelligence With Chapter 2 Release
- Share your workplace safety solutions at 2027 Applied Ergonomics Conference
- Parents No Longer Have to Wait 3 Weeks for a Sleep Consultant: Nora Talks Tonight, Stays for 5 Days, Costs $89